Ronald Witteles

机构：Alnylam Pharmaceuticals (United States), Pfizer (United States), Cardiovascular Institute of the South, Stanford Medicine, Stanford University · ORCID：0000-0002-3043-1472

发表论文 275 篇 · 总被引 14498 次 · h-index 49

代表论文

• Vutrisiran Improves Survival and Reduces Cardiovascular Events in ATTR Amyloid Cardiomyopathy (2025 · Journal of the American College of Cardiology · 被引 30)
• Cardiac Troponin Screening and Clinical Outcomes in Patients Receiving Immunotherapy (2025 · JACC CardioOncology · 被引 14)
• Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (2025 · New England Journal of Medicine · 被引 11)
• Global Practices in Cardiac Imaging for Cardiac Sarcoidosis (2025 · JACC. Cardiovascular imaging · 被引 10)
• Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM (2025 · Journal of the American College of Cardiology · 被引 9)
• Delayed Diagnosis of Transthyretin Amyloid Cardiomyopathy in the Veterans Health Administration (2025 · Journal of the American College of Cardiology · 被引 8)